Journal of Gastric Cancer

  • 제12권3호
  • /
  • Pages.179-186
  • /
  • 2012
  • /
  • 2093-582X(pISSN)
  • /
  • 2093-5641(eISSN)
대한위암학회 (The Korean Gastric Cancer Association)
권호 표지
DOI QR코드

DOI QR Code

18F-2-Deoxy-2-Fluoro-D-Glucose Positron Emission Tomography: Computed Tomography for Preoperative Staging in Gastric Cancer Patients

  • Youn, Seok Hwa (Department of Surgery, Kosin University College of Medicine) ;
  • Seo, Kyung Won (Department of Surgery, Kosin University College of Medicine) ;
  • Lee, Sang Ho (Department of Surgery, Kosin University College of Medicine) ;
  • Shin, Yeon Myung (Department of Surgery, Kosin University College of Medicine) ;
  • Yoon, Ki Young (Department of Surgery, Kosin University College of Medicine)
  • 투고 : 2012.02.29
  • 심사 : 2012.07.30
  • 발행 : 2012.09.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Purpose: The use of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography-computed tomography as a routine preoperative modality is increasing for gastric cancer despite controversy with its usefulness in preoperative staging. In this study we aimed to determine the usefulness of preoperative positron emission tomography-computed tomography scans for staging of gastric cancer. Materials and Methods: We retrospectively analyzed 396 patients' positron emission tomography-computed tomography scans acquired for preoperative staging from January to December 2009. Results: The sensitivity of positron emission tomography-computed tomography for detecting early gastric cancer was 20.7% and it was 74.2% for advanced gastric cancer. The size of the primary tumor was correlated with sensitivity, and there was a positive correlation between T stage and sensitivity. For regional lymph node metastasis, the sensitivity and specificity of the positron emission tomography-computed tomography were 30.7% and 94.7%, respectively. There was no correlation between T stage and maximum standardized uptake value or between tumor markers and maximum standardized uptake value. Fluorodeoxyglucose uptake was detected by positron emission tomography-computed tomography in 24 lesions other than the primary tumors. Among them, nine cases were found to be malignant, including double primary cancers and metastatic cancers. Only two cases were detected purely by positron emission tomography-computed tomography. Conclusions: Positron emission tomography-computed tomography could be useful in detecting metastasis or another primary cancer for preoperative staging in gastric cancer patients, but not for T or N staging. More prospective studies are needed to determine whether positron emission tomography-computed tomography scans should be considered a routine preoperative imaging modality.

키워드

참고문헌

  1. Kelley JR, Duggan JM. Gastric cancer epidemiology and risk factors. J Clin Epidemiol 2003;56:1-9. https://doi.org/10.1016/S0895-4356(02)00534-6
  2. Kim JP. Surgical results in gastric cancer. Semin Surg Oncol 1999;17:132-138. https://doi.org/10.1002/(SICI)1098-2388(199909)17:2<132::AID-SSU8>3.0.CO;2-E
  3. Kim EY, Lee WJ, Choi D, Lee SJ, Choi JY, Kim BT, et al. The value of PET/CT for preoperative staging of advanced gastric cancer: comparison with contrast-enhanced CT. Eur J Radiol 2011;79:183-188. https://doi.org/10.1016/j.ejrad.2010.02.005
  4. Mochiki E, Kuwano H, Katoh H, Asao T, Oriuchi N, Endo K. Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg 2004;28:247-253. https://doi.org/10.1007/s00268-003-7191-5
  5. Dassen AE, Lips DJ, Hoekstra CJ, Pruijt JF, Bosscha K. FDGPET has no definite role in preoperative imaging in gastric cancer. Eur J Surg Oncol 2009;35:449-455. https://doi.org/10.1016/j.ejso.2008.11.010
  6. Kim SK, Kang KW, Lee JS, Kim HK, Chang HJ, Choi JY, et al. Assessment of lymph node metastases using 18F-FDG PET in patients with advanced gastric cancer. Eur J Nucl Med Mol Imaging 2006;33:148-155. https://doi.org/10.1007/s00259-005-1887-8
  7. Hiki Y, Shimao J, Yamao Y, Kobayashi N, Kuranami M, Kikuchi S, et al. The concepts, procedures, and problems related in endoscopic laser therapy of early gastric cancer. A retrospective study on early gastric cancer. Surg Endosc 1989;3:1-6. https://doi.org/10.1007/BF00591306
  8. Ohgami M, Otani Y, Kumai K, Kubota T, Kim YI, Kitajima M. Curative laparoscopic surgery for early gastric cancer: five years experience. World J Surg 1999;23:187-192. https://doi.org/10.1007/PL00013167
  9. Marczell AP, Rosen HR, Hentschel E. Diagnosis and tactical approach to surgery for early gastric carcinoma: a retrospective analysis of the past 16 years in an Austrian general hospital. Gastroenterol Jpn 1989;24:732-736.
  10. Han EJ, Choi WH, Chung YA, Kim KJ, Maeng LS, Sohn KM, et al. Comparison between FDG uptake and clinicopathologic and immunohistochemical parameters in pre-operative PET/CT scan of primary gastric carcinoma. Nucl Med Mol Imaging 2009;43:26-34.
  11. Sarela AI, Miner TJ, Karpeh MS, Coit DG, Jaques DP, Brennan MF. Clinical outcomes with laparoscopic stage M1, unresected gastric adenocarcinoma. Ann Surg 2006;243:189-195. https://doi.org/10.1097/01.sla.0000197382.43208.a5
  12. Yeung HW, Macapinlac H, Karpeh M, Finn RD, Larson SM. Accuracy of FDG-PET in gastric cancer. Preliminary experience. Clin Positron Imaging 1998;1:213-221. https://doi.org/10.1016/S1095-0397(98)00018-1
  13. Stahl A, Ott K, Weber WA, Becker K, Link T, Siewert JR, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. Eur J Nucl Med Mol Imaging 2003;30:288-295. https://doi.org/10.1007/s00259-002-1029-5
  14. Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, et al. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. J Nucl Med 2005;46:1582-1588.
  15. Park MJ, Lee WJ, Lim HK, Park KW, Choi JY, Kim BT. Detecting recurrence of gastric cancer: the value of FDG PET/CT. Abdom Imaging 2009;34:441-447. https://doi.org/10.1007/s00261-008-9424-4
  16. Lordick F, Ott K, Krause BJ, Weber WA, Becker K, Stein HJ, et al. PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial. Lancet Oncol 2007;8:797-805. https://doi.org/10.1016/S1470-2045(07)70244-9
  17. Pieterman RM, van Putten JW, Meuzelaar JJ, Mooyaart EL, Vaalburg W, Koeter GH, et al. Preoperative staging of non-smallcell lung cancer with positron-emission tomography. N Engl J Med 2000;343:254-261. https://doi.org/10.1056/NEJM200007273430404
  18. Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol 2000;18:3202-3210. https://doi.org/10.1200/JCO.2000.18.18.3202
  19. Valk PE, Pounds TR, Hopkins DM, Haseman MK, Hofer GA, Greiss HB, et al. Staging non-small cell lung cancer by wholebody positron emission tomographic imaging. Ann Thorac Surg 1995;60:1573-1581. https://doi.org/10.1016/0003-4975(95)00752-0
  20. Vitola JV, Delbeke D, Sandler MP, Campbell MG, Powers TA, Wright JK, et al. Positron emission tomography to stage suspected metastatic colorectal carcinoma to the liver. Am J Surg 1996;171:21-26. https://doi.org/10.1016/S0002-9610(99)80067-1
  21. Kole AC, Plukker JT, Nieweg OE, Vaalburg W. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer 1998;78:521-527. https://doi.org/10.1038/bjc.1998.526
  22. Ott K, Fink U, Becker K, Stahl A, Dittler HJ, Busch R, et al. Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial. J Clin Oncol 2003;21:4604-4610. https://doi.org/10.1200/JCO.2003.06.574
  23. Mukai K, Ishida Y, Okajima K, Isozaki H, Morimoto T, Nishiyama S. Usefulness of preoperative FDG-PET for detection of gastric cancer. Gastric Cancer 2006;9:192-196. https://doi.org/10.1007/s10120-006-0374-7
  24. Kawamura T, Kusakabe T, Sugino T, Watanabe K, Fukuda T, Nashimoto A, et al. Expression of glucose transporter-1 in human gastric carcinoma: association with tumor aggressiveness, metastasis, and patient survival. Cancer 2001;92:634-641. https://doi.org/10.1002/1097-0142(20010801)92:3<634::AID-CNCR1364>3.0.CO;2-X

피인용 문헌

  1. Is endoscopic ultrasonography still the modality of choice in preoperative staging of gastric cancer? vol.20, pp.38, 2012, https://doi.org/10.3748/wjg.v20.i38.13775
  2. Improving Patient Selection for 18F-FDG PET Scanning in the Staging of Gastric Cancer vol.56, pp.4, 2015, https://doi.org/10.2967/jnumed.114.150946
  3. Incremental diagnostic utility of gastric distension FDG PET/CT vol.43, pp.4, 2012, https://doi.org/10.1007/s00259-015-3211-6
  4. Preoperative Use of PET/CT in Patients With Colorectal and Gastric Cancer and Its Impact on Treatment Decision Making vol.101, pp.7, 2016, https://doi.org/10.9738/intsurg-d-16-00006.1
  5. Predictive Role of the Number of 18 F-FDG-Positive Lymph Nodes Detected by PET/CT for Pre-Treatment Evaluation of Locally Advanced Gastric Cancer vol.11, pp.12, 2012, https://doi.org/10.1371/journal.pone.0166836
  6. Limitations in the use of 18F-FDG PET in the pre-operative staging of gastric cancer: A case series vol.36, pp.None, 2017, https://doi.org/10.1016/j.ijscr.2017.05.026
  7. Comparison of DWI and 18 F-FDG PET/CT for assessing preoperative N-staging in gastric cancer: evidence from a meta-analysis vol.8, pp.48, 2012, https://doi.org/10.18632/oncotarget.21055
  8. Value of multi-slice spiral computed tomography in the diagnosis of metastatic lymph nodes and N-stage of gastric cancer vol.47, pp.1, 2012, https://doi.org/10.1177/0300060518800611